These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

553 related items for PubMed ID: 18246224

  • 1. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.
    Alghasham AA, Barakat YA.
    Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224
    [Abstract] [Full Text] [Related]

  • 2. Circulating visfatin level is correlated with inflammation, but not with insulin resistance.
    Oki K, Yamane K, Kamei N, Nojima H, Kohno N.
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):796-800. PubMed ID: 17634078
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism.
    Chu CH, Lee JK, Wang MC, Lu CC, Sun CC, Chuang MJ, Lam HC.
    Metabolism; 2008 Oct; 57(10):1380-3. PubMed ID: 18803942
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serum levels of the adipokine visfatin are increased in pre-eclampsia.
    Fasshauer M, Waldeyer T, Seeger J, Schrey S, Ebert T, Kratzsch J, Lossner U, Bluher M, Stumvoll M, Faber R, Stepan H.
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):69-73. PubMed ID: 18034779
    [Abstract] [Full Text] [Related]

  • 12. Effect of renin-angiotensin-aldosterone system (RAAS) blockade on visfatin levels in diabetic nephropathy.
    Eyileten T, Sonmez A, Saglam M, Cakir E, Caglar K, Oguz Y, Vural A, Yenicesu M, Yilmaz MI.
    Nephrology (Carlton); 2010 Mar; 15(2):225-9. PubMed ID: 20470283
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance--the Chennai Urban Rural Epidemiology Study (CURES).
    Deepa R, Velmurugan K, Arvind K, Sivaram P, Sientay C, Uday S, Mohan V.
    Metabolism; 2006 Sep; 55(9):1232-8. PubMed ID: 16919544
    [Abstract] [Full Text] [Related]

  • 20. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index.
    Ruge T, Lockton JA, Renstrom F, Lystig T, Sukonina V, Svensson MK, Eriksson JW.
    Metabolism; 2009 Jun; 58(6):860-6. PubMed ID: 19375766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.